Vertex is doubling down on cell and genetic therapy R&D. Having recently opened a 400-person center in Boston, the biotech has set out plans for a 344,000-square-foot facility just around the corner.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,